SUMMARY Varicella-zoster virus glycoprotein gp l/gp3 was purified by affinity chromatography using anti-gpl/gp3 monoclonal antibody 19
Varicella-zoster virus (VZV) induces at least seven glycosylated proteins in infected cells, four of which are major glycoproteins with molecular weights of 115K to 120K (gpl), 80K to 100K (gp2), 62K to 64K (gp3) and 55K (gp5) (Asano & Takahashi, 1979; Grose, 1980; Grose et al., 1981 Grose et al., , 1983 Grose et al., , 1984 Grose & Friedrichs, 1982; Shiraki & Takahashi, 1982; Okuno et al., 1983; Forghani et at., 1984; Keller et al., 1984) .
We have previously described the production and characterization of a monoclonal antibody (MAb 19.1) which recognizes an epitope on the late glycoproteins gpl and gp3 (Vafai et al., 1984) . This antibody has virus-neutralizing activity, reacts with membrane antigens of infected cells as well as with the virion envelope and immunoprecipitates gpl and gp3. In pulse chase experiments, only gpl was detected in pulse-labelled infected cells, whereas both gpl and gp3 were detected during the chase period (Okuno et al., 1983; Vafai et al., 1984) . Immunoprecipitation of purified whole virions and nucleocapsids using MAb 19.1 revealed only gp3 in the virions. These data suggested that gp3 may be the mature form of a viral glycoprotein that is a cleavage product ofgpl (Okuno et al., 1983 ; Vafai et al., 1984) , and it is possible that gp3 plays a role in the interaction of the virion with the host cell surface.
The purpose of this study was to purify VZV glycoproteins gpl/gp3 using MAb 19.1 as an immunoadsorbent and to apply the purified proteins as an immunogen to stimulate the production of virus-neutralizing antibodies in rabbits. This is the first successful attempt at purification of immunogenic VZV glycoproteins.
The MB strain of VZV, originally isolated from a patient with shingles and characterized in this laboratory, was propagated and titrated in BSC-1 monkey cells as previously described (Gilden et al., 1978) .
Immunoglobulin G (19.1 IgG) was purified from mouse ascitic fluid containing MAb 19.1 using a Protein A-Sepharose CL-4B column (Pharmacia). Purified 19.1 IgG was tested by immunofluorescence (IF) for binding to VZV-specific antigens on unfixed infected BSC-1 cells. As shown in Fig. 1 (a) , fluorescence on the surface membrane of infected cells was comparable to that seen with ascitic fluid containing MAb (Fig. 1 b) .
The gpl/gp3 proteins were affinity-purified; the average yield of purified proteins was 40 gg per 2 x l09 VZV-infected cells. SDS PAGE analysis of the purified proteins resulted in the detection ofgpl/gp3 (Fig. 2, lane 1) and two other proteins of apparent tool. wt. of 60K and 45K. The 60K protein could be the cleavage product of the 62K (gp3) protein because it reacts with 0000-6547© 1985 SGM , and rabbit anti-gpl/gp3 serum (c). Cells grown on coverslips were infected with VZV and 24 to 48 h post-infection unfixed cells were incubated with each antibody preparation (diluted 1 : 10) followed by FITC-conjugated goat anti-mouse or anti-rabbit IgG (Cappel Laboratories) diluted 1:10 (Gilden et al., 1978) . No fluorescence was seen after application of antibody to uninfected cells, x 300. IgG was purified as follows. Protein A Sepharose CL-4B was rehydrated in 0.1 M-sodium phosphate buffer pH 7-0, put in the column and washed with 0.1 M-phosphate buffer pH 8.0. The ascitic fluid containing MAb 19.1 was diluted 1:2 in 0.1 M-phosphate buffer pH 8.0, and applied to the column at room temperature. Unbound proteins were removed by extensive washing with 0-1 M-phosphate buffer pH 8.0. IgG was eluted with 25 ml 0.1 M-sodium citrate pH 4-0, and 2.5 ml fractions were collected, neutralized with 1 M-Tris-HCI pH 8.0; the protein concentration in each was determined by the method of Bramhall et al. (1969) . Fractions with the highest protein concentrations were pooled, dialysed against 0.02 M-phosphate buffer pH 7.2, lyophilized overnight, rehydrated in H20 (2 mg/ml) and stored at -70 °C.
h u m a n serum, rabbit anti-VZV sera and ascitic fluid containing M A b 19.1 (Fig. 2 , lanes 2, 3 and 4). W h e n uninfected cell lysates were precipitated along with VZV-infected cell lysates during the purification procedures, the 45K protein was detected in both preparations by S D S -P A G E (data not shown) indicating that this is a host cell protein which binds to the affinity column.
One additional protein of approx, tool. wt. 90K was also detected in the purified gpl/gp3 preparations and was precipitated with ascitic fluid M A b 19.1 (Fig. 2, lane 4 ), but not with h u m a n or rabbit anti-VZV sera (Fig. 2, lanes 2 and 3) . This difference probably reflects the higher concentration of anti-gpl/gp3 antibodies in the ascitic fluid M A b than in h u m a n or rabbit anti-VZV sera. Densitometric quantification from autoradiographs (Fig. 2 , lane 1) revealed higher concentrations of gp3 than of gp 1 in the purified preparation; this could reflect either a greater a m o u n t ofgp3 in the VZV-infected cell lysate or a higher affinity of 19.1 I g G for gp3 t h a n for gpl.
The immunogenicity of purified gp 1/gp3 was then tested in New Zealand rabbits i m m u n i z e d subcutaneously or intramuscularly with purified protein preparations (10 gg) in complete Freund's adjuvant followed by three weekly injections of gpl/gp3 in incomplete F r e u n d ' s adjuvant. Seven days after the last injection, the animals were bled and their sera were tested for the presence of anti-gpl/gp3 antibody by IF, i m m u n o p r e c i p i t a t i o n and neutralization assays. Fig. 1 (c) illustrates the reactivity of rabbit anti-gpl/gp3 serum with unfixed infected cells by IF. The cell pellets were washed with cold phosphate-buffered saline (PBS) and disrupted at 4 °C for 2 h in 4 ml lysis buffer (0.01 M-sodium phosphate pH 7.6, 0.1 M-NaC1, 1 ~ Triton X-100, 0.5~ deoxycholate, 0.1 ~ SDS). The lysates were centrifuged for 20 rain at 2000 r.p.m, then the supernatant at 175000g in a Beckman SW65 rotor for 2 h at 4°C. The supernatants were used for purification of gpl/gp3. One g CNBractivated Sepharose 4B beads was swollen in 0.001 N-HCI for 15 min, washed with 200 ml of 0.001 N-HC1, and resuspended in 6 ml coupling buffer (0.1 M-NaHCO3 pH 8-3, 0.5 M-NaCI). Ten ml purified IgG suspension (2 mg/ml in coupling buffer) was added and the mixture was incubated for 2 to 3 h at room temperature with rocking. To block remaining active groups, the beads were resuspended in 10 ml 0.2 M-glycine pH 8.0, rocked for 2 h at room temperature and washed three times with 0-1 M-sodium acetate pH 4.0, 1 M-NaC1 followed by 0-1 M-NaHCO3 pH 8.0, 1 M-NaC1. The beads were then resuspended in 10 ml TSN buffer (0.01 M-Tris HCI pH 7-5, 0-5 M-NaC1, 0.05~ NP40, 0-1 mM-PMSF) and applied to the column. The column was washed with 10 vol. TSN buffer, and the VZV-infected cell lysates (from 108 cells) were applied and recycled through the column ten times. The column was washed overnight at 4 °C with 21 TSN buffer to remove unbound proteins. Bound proteins were eluted with 50 ml 3 M-KSCN, 0.1 M-Tris-HCI pH 7.8. The eluate was dialysed against three changes (21 each) of 1 mM-Tris-HC1 pH 7.5, 0.01 ~o NP40, 0-01 mM-PMSF, lyophilized overnight, resuspended in 0.1 vol. H20, and either analysed by SDS PAGE (lane 1) or immunoprecipitated with human anti-VZV serum (lane 2), rabbit anti-VZV serum (Wroblewska et aL, 1982) (lane 3), or ascitic fluid containing MAb 19.1 (lane 4) and analysed in a 10~ polyacrylamide gel. For immunoprecipitation, purified gpl/gp3 (4 to 5 ~tg/sample) were incubated at 4 °C for 20 h with 50 ~tl human anti-VZV serum, rabbit anti-VZV serum, or ascitic fluid containing MAb 19.1. Finally, 50 ~tl of a formalin-fixed 10~ suspension of Staphylococcus aureus Cowan I strain (Kessler, 1975) was added, and after 2 h at 4°C, the absorbed immune complexes were washed three times with lysis buffer, resuspended in 50 mM-Tris-HC1 pH 7-4, 150 mM-NaC1, 5mM-EDTA and analysed by gel electrophoresis (Laemmli, 1970) . Gels were processed for fluorography (En3Hance, New England bluclear), dried and exposed to Kodak X-Omat AR film at -70 °C. [35S]Methionine-labelled VZV-infected cell lysates wel'e prepared, immunoprecipitated with the antibodies, and analysed by 10~ SDS-PAGE under reducing (RC), and non-reducing (NC) conditions in which 2-mercaptoethanol was excluded from the sample buffer. Before immunoprecipitation of virus-specific proteins, 1 ml portions of the supernatants were incubated for 20 h at 4°C with 10 Ixl of normal rabbit serum and 50 ~tl ofa 10~ S. aureus suspension followed by centrifugation at 2000 g for 20 min.
Short communication
Immunoprecipitation of [3SS]methionine-labelled VZV-infected cell lysates with rabbit antigpl/gp3 sera followed by SDS PAGE revealed a strong band corresponding to gp3 and a faint band for gpl (Fig. 3) . It is possible that the particular immunogen preparation contained a higher concentration of gp3. Alternatively, gp3 might elicit a better immune response than gp 1. SDS-PAGE analysis under non-reducing conditions revealed a 130K protein (Fig. 3, lane  3) , but not the 62K protein band (gp3), consistent with previous results indicating that gp3 is a disulphide-linked dimer Vafai et al., 1984) . This dimer form was detected by MAb 19.1 as well as by the rabbit serum prepared against purified proteins.
The rabbit anti-gpl/gp3 sera were also examined for virus neutralizing activity. Neutralization was performed by the constant virus-varying serum technique (Schmidt & Lennette, 1975) . Cells (10 s) were infected with VZV by co-cultivation (Gilden et al., 1978) . After 4 days, when infected cultures showed 80 to 90~ c.p.e., cells were scraped into the tissue culture medium, centrifuged at 2000g for 20 min at 4 °C and the cell pellet was resuspended in 4 ml of serum-free MEM. The cell suspension was homogenized (i00 strokes) in a Teflon-coated homogenizer to break the cytoplasmic and nuclear membranes. The homogenates were centrifuged at 800g for 10 min and the supernatants were used for neutralization tests. Aliquots (0.5 ml) containing 100 to 200 p.f.u, were mixed with equal volumes of serial dilutions (1:2 to 1:1024) of rabbit anti-gp 1/gp3 or preimmune serum. The mixtures were incubated at 37 °C for 1 h and inoculated into two wells of BSC-1 cells grown in six-well plates. After 3 h adsorption at 37 °C, the inoculum was removed, cells were overlaid with MEM containing 2~ foetal bovine serum (FBS) and incubated at 37 °C for 6 to 7 days. Cells were fixed with formaldehyde, stained with cresyl violet and plaques were counted. The results showed that rabbit anti-gpl/gp3 serum diluted 1:2 to 1:32 neutralized virus infectivity by 91 to 94~ and 1:1024 diluted serum reduced plaque counts by 60 to 63 ~, demonstrating positive seroconversion in animals immunized with purified gpl/gp3.
Previously, we showed that gpl/gp3 proteins are expressed on the VZV-infected cell surface, gp3 is found in the envelope of VZV virions and that MAb 19.1 prepared against VZV-induced gpl/gp3 glycoproteins is capable of neutralizing VZV infectivity (Vafai et al., 1984) . In the present study, we have shown that purified gpl/gp3 proteins retain immunogenic activity and stimulate the production of neutralizing antibody, suggesting that gpl/gp3 proteins may play a role in the interaction of VZV and the cell surface in the initial stage of viral infection.
